Trending...
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand - 107
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position - 105
- The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation - 103
INNOVATION PARK, N.C. ~ IQVIA Holdings Inc. (NYSE:IQV) announced today that its wholly-owned subsidiary, IQVIA Inc., has allocated a new term B loan due 2031 of approximately $1,500 million. This loan was upsized due to lender demand.
The proceeds from the new term loan B and the offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 will be used to repay outstanding Euro-denominated and U.S.-denominated term B loans under the Borrower's senior secured credit facilities, as well as to pay fees and expenses related to the Borrower's Notes offering and the Borrower's credit agreement amendment in respect of the New Term Loan B.
In connection with the allocation of the New Term Loan B, IQVIA entered into a cross-currency swap agreement which will effectively convert the New Term Loan B into a euro-denominated borrowing at prevailing euro interest rates to hedge exposure to USD-denominated indebtedness created by the New Term Loan B. The effective net borrowing rate to IQVIA will be 4.9015%, inclusive of the yield on the New Term Loan B and the beneficial impact of the cross-currency swap.
More on ncarol.com
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to life sciences industry. It creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is also a global leader in protecting individual patient privacy by using a wide variety of privacy-enhancing technologies and safeguards while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with precise treatment paths for better outcomes.
The company's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures.
The proceeds from the new term loan B and the offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 will be used to repay outstanding Euro-denominated and U.S.-denominated term B loans under the Borrower's senior secured credit facilities, as well as to pay fees and expenses related to the Borrower's Notes offering and the Borrower's credit agreement amendment in respect of the New Term Loan B.
In connection with the allocation of the New Term Loan B, IQVIA entered into a cross-currency swap agreement which will effectively convert the New Term Loan B into a euro-denominated borrowing at prevailing euro interest rates to hedge exposure to USD-denominated indebtedness created by the New Term Loan B. The effective net borrowing rate to IQVIA will be 4.9015%, inclusive of the yield on the New Term Loan B and the beneficial impact of the cross-currency swap.
More on ncarol.com
- Make Your Move to Luxury Living at Heritage at Hopewell with Rates Starting at Just 3.750% (5.803% APR)
- Scott Glickson Joins STS Capital Partners as Managing Director
- BREAKTHROUGH TROP2 Research Reveals New REQORSA® Opportunities as Roche Collaboration Strengthens Precision Lung Cancer Strategy
- Designed for Healthcare: How TOLI Is Rethinking Functional Flooring
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Dallas–Fort Worth
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to life sciences industry. It creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is also a global leader in protecting individual patient privacy by using a wide variety of privacy-enhancing technologies and safeguards while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with precise treatment paths for better outcomes.
The company's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures.
Filed Under: Business
0 Comments
Latest on ncarol.com
- Not a Black Box Launches TalentOS, the First Talent Harness Operating System
- A Diwali Celebration with Heritage at South Brunswick Residents & American Properties
- Law Offices of Larry E. Bray, P.A. Wins Fourth District Appeal Clarifying Limits of Florida's Offer of Judgment Statute
- Holiday Magic Returns to Downtown Downers Grove November 27-29
- What If the Greatest Gift This Holiday Season Came in a Dream of Your Loved One in Spirit?
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis
- LGF Lab Gas Flow Launches Fully Automatic Laboratory Gas Changeover Manifold System with Ultra High Purity Gas Regulator Valve
- Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
- Inaugural 12 Trees of Christmas gala raises $525,000 for DMG research and family support
- BitTitan Expands MigrationWiz with SharePoint Sites Migration and Simplified Collaboration Licensing
- Olympic champion Katie Moon to compete at Pole Vault in Paradise in Key West
- The Seaside Art Gallery Presents
- Smith Strong Merges With Gravis Law, Bringing Gravis Law to Virginia
- Asheville-Based KayeDinero Surpasses 100-Track Goal as Detroit Lions Win 35-10 in Munich
- Turkish Engineer Who Cracked Wall Street's Algorithm Launches Hermes AI Analyzer
- Nious Media Expands Gaming Coverage With 2026 Game & Geek Expo Special
- UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
- The Dark Chocolate Nutcracker Marks 15 Years
- Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
- Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026